JG
CLB icon

Joel Greenblatt’s Core Laboratories CLB Stock Holding History

Joel Greenblatt’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,810
Closed -$187K – 1565
2024
Q4 		$187K Buy
+10,810
New +$209K ﹤0.01% 1374
2023
Q4 		– Sell
-8,791
Closed -$211K – 1347
2023
Q3 		$211K Buy
8,791
+2
+0% +$49 ﹤0.01% 1224
2023
Q2 		$204K Buy
+8,789
New +$199K ﹤0.01% 1229
2022
Q2 		– Sell
-7,543
Closed -$239K – 1137
2022
Q1 		$239K Buy
+7,543
New +$211K 0.01% 1019
2021
Q4 		– Sell
-11,338
Closed -$315K – 1149
2021
Q3 		$315K Sell
11,338
-1,999
-15% -$60.9K 0.01% 809
2021
Q2 		$519K Sell
13,337
-16,968
-56% -$608K 0.02% 667
2021
Q1 		$872K Sell
30,305
-12,128
-29% -$414K 0.04% 520
2020
Q4 		$1.13M Sell
42,433
-398
-0.9% -$8.13K 0.04% 504
2020
Q3 		$654K Buy
42,831
+7,454
+21% +$156K 0.02% 665
2020
Q2 		$719K Sell
35,377
-83,909
-70% -$1.5M 0.02% 653
2020
Q1 		$1.23M Buy
119,286
+91,348
+327% +$2.55M 0.03% 502
2019
Q4 		$1.05M Sell
27,938
-29,555
-51% -$1.33M 0.02% 610
2019
Q3 		$2.68M Sell
57,493
-5,414
-9% -$252K 0.05% 403
2019
Q2 		$3.29M Buy
+62,907
New +$3.69M 0.05% 403
2019
Q1 		– Sell
-15,242
Closed -$909K – 1177
2018
Q4 		$909K Buy
+15,242
New +$1.32M 0.01% 653
2018
Q3 		– Sell
-19,895
Closed -$2.51M – 942
2018
Q2 		$2.51M Buy
+19,895
New +$2.42M 0.04% 450
2016
Q1 		– Sell
-2,536
Closed -$276K – 980
2015
Q4 		$276K Sell
2,536
-112
-4% -$12.8K ﹤0.01% 769
2015
Q3 		$264K Sell
2,648
-40,058
-94% -$4.36M ﹤0.01% 820
2015
Q2 		$4.87M Sell
42,706
-35,863
-46% -$4.35M 0.04% 453
2015
Q1 		$8.21M Buy
78,569
+9,745
+14% +$1.04M 0.06% 369
2014
Q4 		$8.28M Buy
+68,824
New +$9.04M 0.07% 350

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Joel Greenblatt's CLB Position: Q1 2025 in Review

Joel Greenblatt sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 10,810 shares — an estimated $187K sold.

Joel Greenblatt first reported a position in CLB in Q4 2014 and held it in 21 quarters. The position peaked at $8.28M in Q4 2014. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Joel Greenblatt reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Joel Greenblatt sold 10,810 Core Laboratories shares in Q1 2025, an estimated $187K.
  • Joel Greenblatt first reported a position in Core Laboratories in Q4 2014 and held it in 21 quarters.
  • Joel Greenblatt's Core Laboratories position peaked at $8.28M in Q4 2014.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Gotham Asset Management's 13F filing for Q1 2025, filed 15 May 2025.